Growth Metrics

Nexalin Technology (NXL) Enterprise Value (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Enterprise Value data on record, last reported at -$4.4 million in Q3 2025.

  • For Q3 2025, Enterprise Value rose 51.77% year-over-year to -$4.4 million; the TTM value through Sep 2025 reached -$4.4 million, up 51.77%, while the annual FY2024 figure was -$3.5 million, 26.53% up from the prior year.
  • Enterprise Value reached -$4.4 million in Q3 2025 per NXL's latest filing, up from -$10.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$661778.0 in Q4 2021 and bottomed at -$10.7 million in Q2 2025.
  • Average Enterprise Value over 5 years is -$5.2 million, with a median of -$4.5 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: surged 81.93% in 2024, then plummeted 1163.31% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$661778.0 in 2021, then tumbled by 956.84% to -$7.0 million in 2022, then skyrocketed by 32.28% to -$4.7 million in 2023, then grew by 26.53% to -$3.5 million in 2024, then fell by 25.08% to -$4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$4.4 million in Q3 2025, -$10.7 million in Q2 2025, and -$2.9 million in Q1 2025.